Literature DB >> 104923

Possible mechanisms of the first step of the classical complement activation pathway: binding and activation of C1.

G Füst, G A Medgyesi, E Rajnavölgyi, M Csécsi-Nagy, K Czikora, J Gergely.   

Abstract

Different immunoglobulin preparations of human monoclonal IgM, normal human and rat IgG, as well as purified rabbit antibodies were treated by various methods, fragmentation, aggregation and complexing with antigen. The ability of the treated and untreated preparations to fix isolated human C1, to activate the classical complement pathway (to consume C4 in normal human serum) were compared. It was found that the different methods affected the conformation of the immunoglobulin molecules in different ways and induced changes to a greater or lesser extent in the two capacities of the preparations tested. In the case of the monoclonal IgM preparation a strong C1-fixation was observed without measurable complement activation. Other preparations, interfacially aggregated human IgG, BSA-anti-BSA and OA-anti-OA immune complexes had a very weak C1-fixing but a marked complement activating capacity. Some preparations, e.g. heat-aggregated IgG, both fixed and activated C1 effectively, aggregates with a complement-activating capacity without C1-fixing effect were separated by gel-filtration. It was demonstrated further, that at a given time only a part of the activated C1 molecules could be found fixed to the immunoglobulins, the other part was released into the fluid phase after activation. On the basis of the results of this and previous studies a hypothesis is proposed suggesting three possible results of the interaction between C1 and the different preparations: (1) firm fixation and activation; (2) binding not followed by activation and (3) a transient binding leading to activation. The possible application of this hypothesis for the interpretation of the results of the different methods for detecting immune complexes is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 104923      PMCID: PMC1457433     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

Review 1.  Complement.

Authors:  H J Müller-Eberhard
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

2.  Study of the interaction between monoclonal IgM proteins and the complement system.

Authors:  G Füst; M Csécsi-Nagy; G A Medgyesi; J Kulics; J Gergely
Journal:  Immunochemistry       Date:  1976-10

3.  Inhibition by epsilon-aminocaproic acid of the activation of the first component of the complement system.

Authors:  N A Soter; K F Austen; I Gigli
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

4.  Solid-phase enzyme immunoassay or radioimmunoassay for the detection of immune complexes based on their recognition by conglutinin: conglutinin-binding test. A comparative study with 125I-labelled Clq binding and Raji-cell RIA tests.

Authors:  P Casali; A Bossus; N A Carpentier; P H Lambert
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

5.  Immune hemolysis: a simplified method for the preparation of EAC'4 with guinea pig or with human complement.

Authors:  T Borsos; H J Rapp
Journal:  J Immunol       Date:  1967-08       Impact factor: 5.422

6.  Anticomplementary activity of human immunoglobulin G. I. Mechanism of the artifactual increase in anticomplementary activity of IgG during the assay.

Authors:  S I Miekka; I Gozze
Journal:  Vox Sang       Date:  1975       Impact factor: 2.144

7.  Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.

Authors:  R H Zubler; G Lange; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

8.  C1 fixation and classical complement pathway activation by a fragment of the Cmu4 domain of IgM.

Authors:  M M Hurst; J E Volanakis; R M Stroud; J C Bennett
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

9.  C1q deviation test for the detection of immune complexes, aggregates of IgG, and bacterial products in human serum.

Authors:  A T Sobel; V A Bokisch; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

10.  Binding of soluble immune complexes to human lymphoblastoid cells. II. Use of Raji cells to detect circulating immune complexes in animal and human sera.

Authors:  A N Theofilopoulos; C B Wilson; V A Bokisch; F J Dixon
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

View more
  8 in total

1.  Quantitative analysis of the interaction between immune complex and C1q complement subcomponent. The role of interdomain interactions in rabbit IgG in binding of C1q to immune precipitates.

Authors:  F Vonderviszt; J Török; S Lakatos; F Kilár; P Závodszky
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

2.  Biological and pharmacokinetic properties of a novel immunoglobulin-CD4 fusion protein.

Authors:  J B Lyczak; S L Morrison
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

3.  The relationship between the binding ability and the rate of activation of the complement component C1.

Authors:  E J Folkerd; B Gardner; N C Hughes-Jones
Journal:  Immunology       Date:  1980-09       Impact factor: 7.397

4.  Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals.

Authors:  Eva Biró; Rienk Nieuwland; Paul P Tak; Loes M Pronk; Marianne C L Schaap; Augueste Sturk; C Erik Hack
Journal:  Ann Rheum Dis       Date:  2007-01-29       Impact factor: 19.103

5.  Activation of effector functions by immune complexes of mouse IgG2a with isotype-specific autoantibodies.

Authors:  E Rajnavölgyi; G Fazekas; J Lund; M Daeron; J L Teillaud; R Jefferis; W H Fridman; J Gergely
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

6.  Influence of aggregate size on the binding and activation of the first component of human complement by soluble IgG aggregates.

Authors:  G Doekes; L A Vanes; M R Daha
Journal:  Immunology       Date:  1982-04       Impact factor: 7.397

7.  Analysis of the anticomplementary activity in sera of three African patients with parasitic and bacteriological infections.

Authors:  M Loos; M P Dierich
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

8.  Radioconglutinin-binding azssay for circulating immune complexes: a new method.

Authors:  K V Johny; M K Dasgupta; B Singh; J B Dossetor
Journal:  Clin Exp Immunol       Date:  1980-06       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.